| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/06/14 | 05 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/14 | 05 : 30 | Business Wire | Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/07 | 04 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/07 | 04 : 30 | Business Wire | Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/06 | 04 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/06 | 04 : 00 | Business Wire | Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/04 | 04 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/06/04 | 04 : 00 | Business Wire | Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/05/31 | 22 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/05/31 | 22 : 00 | Business Wire | Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/05/31 | 05 : 30 | Business Wire | Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/04/16 | 05 : 30 | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/04/12 | 06 : 00 | Business Wire | Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/03/27 | 03 : 30 | Business Wire | Novo Integrated Sciences Provides Update on Certain Current Actions and Events | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/22 | 06 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/22 | 06 : 05 | Business Wire | Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/21 | 04 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/21 | 04 : 00 | Business Wire | Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/17 | 04 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/17 | 04 : 00 | Business Wire | Novo Integrated Sciences Appoints New President | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/16 | 07 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/02/07 | 02 : 00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/01/23 | 06 : 31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/01/23 | 06 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/01/23 | 06 : 30 | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2024/01/17 | 06 : 05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2023/12/20 | 06 : 45 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2023/12/20 | 06 : 30 | Business Wire | Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2023/12/15 | 07 : 01 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 2023/12/15 | 07 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |